{{Rsnum
|rsid=4234853
|Gene=PCGF3
|Chromosome=4
|position=741362
|Orientation=plus
|GMAF=0.1915
|Gene_s=PCGF3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 38.9 | 50.4
| HCB | 4.4 | 36.5 | 59.1
| JPT | 3.5 | 22.1 | 74.3
| YRI | 0.0 | 9.5 | 90.5
| ASW | 0.0 | 14.0 | 86.0
| CHB | 4.4 | 36.5 | 59.1
| CHD | 5.5 | 31.2 | 63.3
| GIH | 5.9 | 39.6 | 54.5
| LWK | 0.0 | 14.7 | 85.3
| MEX | 1.7 | 32.8 | 65.5
| MKK | 1.3 | 17.9 | 80.8
| TSI | 6.9 | 48.0 | 45.1
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22443383
|Trait=None
|Title=Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project.
|RiskAllele=A
|Pval=0.000006
|OR=4.8800
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}